7 Current news of High-Tech Gründerfonds Management
rssHigh-Tech Gründerfonds and STIFT invest into molecular cancer diagnostics from Jena
04-19-2012
Chemical alterations of the genetic information specifically occuring during carcinogenesis provide the basis for the innovative diagnostic tests that are developed by the newly established oncgnostics GmbH in Jena. These tests allow not only for an earlier, but also a more accurate detection ...
03-04-2011
SAW Instruments has completed in early February its second financing round of one million EUR and is aiming to reach break-even in fiscal year 2012. “The funds will be invested in particular in the expansion of sales & marketing activities and extending our product portfolio.” says ...
02-22-2011
PEPperPRINT has won German Industry’s Innovation Award 2010 in the startup category. The biotech company from Heidelberg, Germany, was awarded in line of 30th German Industry’s Gala at the Congress Center Frankfurt by Federal Minister of Education and Research, Dr. Annette ...
10-19-2010
High-Tech Gründerfonds and MAZ level one investing about EUR 550k in PAS-Analytik GmbH. The aim with this investment is to further develop the technology of laser-based photoacoustics and to push entry into the market for industrial and medical gas analysis. PAS-Analytik GmbH was established ...
07-19-2010
High-Tech Gründerfonds and Bayern Kapital are investing about EUR 400k in Chromotek GmbH. The investment is intended to fund research and development work aimed at ensuring successful market entry for chromobody technology in the field of living cell analysis. Chromotek GmbH, an enterprise ...
07-15-2010
Intana Bioscience GmbH announced that it has entered an agreement with Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V., Beerse, Belgium. Under the agreement, Intana will provide its proprietary Fluorescent Cross Correlation Spectroscopy (FCCS) ...
03-26-2010
Humedics markets a method for instantaneous measurement of liver function at the patient’s bedside. Known as the LiMAx Test, which was developed at the Charité University Hospital in Berlin by Dr Martin Stockmann and refined into a measurement system together with Prof. Karsten Heyne of ...
